Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-2_16-cv-02308/USCOURTS-caed-2_16-cv-02308-23/pdf.json

Nature of Suit Code: 245
Nature of Suit: Real Property Product Liability
Cause of Action: 28:1331 Fed. Question

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF CALIFORNIA

DOMINGO L. CLEVELAND, SR.,

Plaintiff,

v.

JANSSEN PHARMACEUTICALS,

Defendant.

No. 2:16-cv-02308 MCE AC PS

ORDER

Plaintiff is proceeding in this action in pro per. The matter was referred to a United States 

Magistrate Judge pursuant to Local Rule 302(c)(21).

On November 18, 2019, the magistrate judge filed findings and recommendations herein 

which were served on all parties and which contained notice to all parties that any objections to 

the findings and recommendations were to be filed within twenty-one days. ECF. NO. 111. On 

January 13, 2020, plaintiff filed objections to the findings and recommendations. ECF No. 114. 

On January 22, 2020, defendant filed a response to the objections. ECF No. 116.

In accordance with the provisions of 28 U.S.C. § 636(b)(1)(C) and Local Rule 304, this 

court has conducted a de novo review of this case. Having carefully reviewed the entire file, the 

court finds the findings and recommendations to be supported by the record and by proper 

analysis.

Accordingly, IT IS HEREBY ORDERED that:

Case 2:16-cv-02308-MCE-AC Document 119 Filed 03/10/20 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

2

1. The findings and recommendations filed November 18, 2019, are adopted in full; and

2. Defendant’s motion for summary judgment (ECF No. 93) is GRANTED, judgment is 

entered in favor of the defendant, and this case is CLOSED.

IT IS SO ORDERED.

Dated: March 10, 2020

Case 2:16-cv-02308-MCE-AC Document 119 Filed 03/10/20 Page 2 of 2